156 Einträge gefunden

1. Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations

   1. Rajwa, Pawel
   2. Quhal, Fahad
   3. Pradere, Benjamin
   4. Gandaglia, Giorgio
   5. Ploussard, Guillaume
   6. Leapman, Michael S
   7. Gore, John L

   2023 - Forschungsinformationssystem des UKE
2. Urethral Sphincter Length but Not Prostatic Apex Shape in Preoperative MRI Is Associated with Mid-Term Continence Rates after Radical Prostatectomy

   1. Hoeh, Benedikt
   2. Wenzel, Mike
   3. Müller, Matthias
   4. Wittler, Clarissa
   5. Schlenke, Eva
   6. Hohenhorst, Jan L
   7. Köllermann, Jens

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Concordance of biopsy and pathologic ISUP grading in salvage radical prostatectomy patients for recurrent prostate cancer

   1. Preisser, Felix
   2. Würnschimmel, Christoph
   3. Pose, Randi M
   4. Heinze, Alexander
   5. Steuber, Thomas
   6. Michl, Uwe
   7. Salomon, Georg

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. Oncologic outcomes of organ-confined Gleason grade group 4-5 prostate cancer after radical prostatectomy

   1. Preisser, Felix
   2. Wang, Nuowei
   3. Abrams-Pompe, Raisa S
   4. Chun, Felix K-H
   5. Graefen, Markus
   6. Huland, Hartwig
   7. Tilki, Derya

   2022 - Forschungsinformationssystem des UKE
5. The current role of precision surgery in oligometastatic prostate cancer

   1. von Deimling, Markus
   2. Rajwa, Pawel
   3. Tilki, Derya
   4. Heidenreich, Axel
   5. Pallauf, Maximilian
   6. Bianchi, Alberto
   7. Yanagisawa, Takafumi

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
6. Immuno-oncology therapy in metastatic bladder cancer: A systematic review and network meta-analysis

   1. Chierigo, Francesco
   2. Wenzel, Mike
   3. Würnschimmel, Christoph
   4. Flammia, Rocco Simone
   5. Horlemann, Benedikt
   6. Tian, Zhe
   7. Saad, Fred

   2022 - Forschungsinformationssystem des UKE
7. Impact of positive surgical margin length and Gleason grade at the margin on oncologic outcomes in patients with nonorgan-confined prostate cancer

   1. Preisser, Felix
   2. Heinze, Alexander
   3. S Abrams-Pompe, Raisa
   4. Budäus, Lars
   5. Chun, Felix K-H
   6. Graefen, Markus
   7. Huland, Hartwig

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
8. Nomogram Predicting Downgrading in National Comprehensive Cancer Network High-risk Prostate Cancer Patients Treated with Radical Prostatectomy

   1. Wenzel, Mike
   2. Würnschimmel, Christoph
   3. Chierigo, Francesco
   4. Flammia, Rocco Simone
   5. Tian, Zhe
   6. Shariat, Shahrokh F
   7. Gallucci, Michele

   2022 - Forschungsinformationssystem des UKE
9. Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art review

   1. Heidegger, Isabel
   2. Kesch, Claudia
   3. Kretschmer, Alexander
   4. Tsaur, Igor
   5. Ceci, Francesco
   6. Valerio, Massimo
   7. Tilki, Derya

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
10. PSMA PET predicts metastasis-free survival in the setting of salvage radiotherapy after radical prostatectomy

    1. Wenzel, Mike
    2. Hussein, Rada
    3. Maurer, Tobias
    4. Karakiewicz, Pierre I
    5. Tilki, Derya
    6. Graefen, Markus
    7. Würnschimmel, Christoph

    2022 - Forschungsinformationssystem des UKE
11. The impact of time to prostate specific antigen nadir on biochemical recurrence and mortality rates after radiation therapy for localized prostate cancer

    1. Wenzel, Mike
    2. Dariane, Charles
    3. Saad, Fred
    4. Karakiewicz, Pierre I
    5. Mandel, Philipp
    6. Chun, Felix K H
    7. Tilki, Derya

    2022 - Forschungsinformationssystem des UKE
12. Adjuvant Versus Early Salvage Radiation Therapy After Radical Prostatectomy for pN1 Prostate Cancer and the Risk of Death

    1. Tilki, Derya
    2. Chen, Ming-Hui
    3. Wu, Jing
    4. Huland, Hartwig
    5. Graefen, Markus
    6. D'Amico, Anthony V

    2022 - Forschungsinformationssystem des UKE - frei zugänglich
13. Multimodal treatment of high-risk and locally advanced prostate cancer, Multimodale Therapie des Hochrisiko- und lokal fortgeschrittenen Prostatakarzinoms

    1. Preisser, Felix
    2. Tilki, Derya

    2022 - Forschungsinformationssystem des UKE - frei zugänglich
14. Other-cause mortality and access to care in metastatic renal cell carcinoma according to race/ethnicity

    1. Sorce, Gabriele
    2. Hoeh, Benedikt
    3. Hohenhorst, Lukas
    4. Panunzio, Andrea
    5. Tappero, Stefano
    6. Tian, Zhe
    7. Larcher, Alessandro

    2022 - Forschungsinformationssystem des UKE
15. Rates of metastatic prostate cancer in newly diagnosed patients: Numbers needed to image according to risk level

    1. Sorce, Gabriele
    2. Hoeh, Benedikt
    3. Flammia, Rocco S
    4. Chierigo, Francesco
    5. Hohenhorst, Lukas
    6. Panunzio, Andrea
    7. Nimer, Nancy

    2022 - Forschungsinformationssystem des UKE
16. Temporal trends, tumor characteristics and stage-specific survival in penile non-squamous cell carcinoma vs. squamous cell carcinoma

    1. Wenzel, Mike
    2. Siron, Nicolas
    3. Collà Ruvolo, Claudia
    4. Nocera, Luigi
    5. Würnschimmel, Christoph
    6. Tian, Zhe
    7. Shariat, Shahrokh F

    2022 - Forschungsinformationssystem des UKE - frei zugänglich
17. Preprostatic lymph nodes in prostate cancer hot or not?:Impact on oncological outcome after radical prostatectomy

    1. Korten, Michael
    2. Pose, Randi M
    3. Graefen, Markus
    4. Tilki, Derya
    5. Michl, Uwe
    6. Knipper, Sophie
    7. Beyer, Burkhard

    2022 - Forschungsinformationssystem des UKE
18. Overall Survival After Systemic Treatment in High-volume Versus Low-volume Metastatic Hormone-sensitive Prostate Cancer: Systematic Review and Network Meta-analysis

    1. Wenzel, Mike
    2. Würnschimmel, Christoph
    3. Nocera, Luigi
    4. Collà Ruvolo, Claudia
    5. Tian, Zhe
    6. Shariat, Shahrokh F
    7. Saad, Fred

    2022 - Forschungsinformationssystem des UKE
19. Grade and stage misclassification in intermediate unfavorable-risk prostate cancer radiotherapy candidates

    1. Sorce, Gabriele
    2. Flammia, Rocco Simone
    3. Hoeh, Benedikt
    4. Chierigo, Francesco
    5. Hohenhorst, Lukas
    6. Panunzio, Andrea
    7. Stabile, Armando

    2022 - Forschungsinformationssystem des UKE - frei zugänglich
20. Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis

    1. Wenzel, Mike
    2. Nocera, Luigi
    3. Collà Ruvolo, Claudia
    4. Würnschimmel, Christoph
    5. Tian, Zhe
    6. Shariat, Shahrokh F
    7. Saad, Fred

    2022 - Forschungsinformationssystem des UKE - frei zugänglich